-
1
-
-
80051669014
-
An overview on the Genetic of Rheumatoid Arthritis: a never-ending story
-
Apr 22.
-
Perricone C, Ceccarelli F, Valesini G. An overview on the Genetic of Rheumatoid Arthritis: a never-ending story. Autoimmun Rev. 2011 Apr 22.
-
(2011)
Autoimmun Rev.
-
-
Perricone, C.1
Ceccarelli, F.2
Valesini, G.3
-
2
-
-
80051669017
-
Angiogenesis in Rheumatoid Arthritis: a disease specific process or a common response to chronic inflammation?
-
Apr 27.
-
Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, Perricone R, Giacomelli R. Angiogenesis in Rheumatoid Arthritis: a disease specific process or a common response to chronic inflammation? Autoimmun. Rev. 2011 Apr 27.
-
(2011)
Autoimmun. Rev.
-
-
Marrelli, A.1
Cipriani, P.2
Liakouli, V.3
Carubbi, F.4
Perricone, C.5
Perricone, R.6
Giacomelli, R.7
-
3
-
-
80051672429
-
Role of the Complement System in Rheumatoid Arthritis and Psoriatic Arthritis: relationship with anti-TNF inhibitors
-
Apr 27.
-
Ballanti E, Perricone C, Di Muzio G, Kroegler B, Chimenti MS, Graceffa D, Perricone R. Role of the Complement System in Rheumatoid Arthritis and Psoriatic Arthritis: relationship with anti-TNF inhibitors. Autoimmun Rev. 2011 Apr 27.
-
(2011)
Autoimmun Rev.
-
-
Ballanti, E.1
Perricone, C.2
Di Muzio, G.3
Kroegler, B.4
Chimenti, M.S.5
Graceffa, D.6
Perricone, R.7
-
5
-
-
79958242639
-
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk
-
Apr 22.
-
Gremese E, Ferraccioli G. The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev. 2011 Apr 22.
-
(2011)
Autoimmun Rev.
-
-
Gremese, E.1
Ferraccioli, G.2
-
6
-
-
80051611724
-
Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issues
-
Apr 22.
-
Cacciapaglia F, Navarini L, Menna P, Salvatorelli E, Minotti G, Afeltra A. Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issues. Autoimmun Rev. 2011 Apr 22.
-
(2011)
Autoimmun Rev.
-
-
Cacciapaglia, F.1
Navarini, L.2
Menna, P.3
Salvatorelli, E.4
Minotti, G.5
Afeltra, A.6
-
7
-
-
80051670470
-
Anti-TNF discontinuation in rheumatoid and psoriatic arthritis: is it possible after disease remission?
-
Apr 21.
-
Chimenti MS, Graceffa D, Perricone R. Anti-TNF discontinuation in rheumatoid and psoriatic arthritis: is it possible after disease remission? Autoimmun Rev. 2011 Apr 21.
-
(2011)
Autoimmun Rev.
-
-
Chimenti, M.S.1
Graceffa, D.2
Perricone, R.3
-
9
-
-
80051669816
-
Novel Opportunities in automated classification of Antinuclear Antibodies on HEp-2 cells
-
Apr 22.
-
Rigon A, Buzzulini F, Soda P, Onofri L, Arcarese L, Iannello G, Afeltra A. Novel Opportunities in automated classification of Antinuclear Antibodies on HEp-2 cells. Autoimmun Rev. 2011 Apr 22.
-
(2011)
Autoimmun Rev.
-
-
Rigon, A.1
Buzzulini, F.2
Soda, P.3
Onofri, L.4
Arcarese, L.5
Iannello, G.6
Afeltra, A.7
-
10
-
-
80051667568
-
Angiogenic cytokines and growth factors in systemic sclerosis
-
Apr 28.
-
Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R. Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev. 2011 Apr 28.
-
(2011)
Autoimmun Rev.
-
-
Liakouli, V.1
Cipriani, P.2
Marrelli, A.3
Alvaro, S.4
Ruscitti, P.5
Giacomelli, R.6
-
12
-
-
80051607473
-
B cells in systemic sclerosis: a possible target for therapy
-
Apr 22
-
Bosello S, De Luca G, Tolusso B, Lama G, Angelucci C, Sica G, Ferraccioli G. B cells in systemic sclerosis: a possible target for therapy. Autoimmun Rev. 2011 Apr 22.
-
(2011)
Autoimmun Rev.
-
-
Bosello, S.1
De Luca, G.2
Tolusso, B.3
Lama, G.4
Angelucci, C.5
Sica, G.6
Ferraccioli, G.7
|